Drugs for Non-small Cell Lung Cancer

2017-2025 World Drugs for Non-small Cell Lung Cancer Market Research Report (by Product Type, End-User / Application and Regions / Countries)

Report ID: HeyReport 56078 | Number of pages: 168 | Publish Date: Nov 2019 | Category: Medical Devices and Consumables 
Summary


This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.
The report includes as follows:
The report provides current data, historical overview and future forecast.
The report includes an in-depth analysis of the Global market for Drugs for Non-small Cell Lung Cancer , covering Global total and major region markets.
The data of 2017-2025 are included. All-inclusive market are given through data on sales, consumption, and prices (Global total and by major regions). 
The report provides introduction of leading Global manufacturers.
Drugs for Non-small Cell Lung Cancer market prospects to 2025 are included (in sales, consumption and price).
Market Segment as follows:
By Region / Countries
    North America (U.S., Canada, Mexico)
    Europe (Germany, U.K., France, Italy, Russia, Spain etc)
    Asia-Pacific (China, India, Japan, Southeast Asia etc)
    South America (Brazil, Argentina etc)
    Middle East & Africa (Saudi Arabia, South Africa etc)
By Type
    Radiofrequency Ablation (RFA) 
    Radiation Therapy 
    Chemotherapy 
    Targeted Therapies 
    Immunotherapy
By End-User / Application
    Hospital 
    Clinic 
    Others
By Company
    Bristol-Myers Squibb 
    GlaxoSmithKline 
    Menarini 
    Sanofi 
    Ziopharm Oncology 
    Alchemia 
    Amgen 
    Apotex 
    BioMarin Pharmaceutical 
    CellAct Pharma 
    Cerulean Pharma 
    Cipla 
    Cornerstone Pharmaceuticals 
    Curis 
    CytRx 
    Eli Lilly 
    Exelixis 
    Fresenius Kabi 
    Genentech 
    Hikma Pharmaceuticals 
    Hospira 
    Intas Pharmaceuticals 
    Karyopharm Therapeutics 
    Kyowa Hakko Kirin 
    Ligand Pharmaceuticals
Interested in this report?
Get your sample now!
Download Sample 
Table of Content

1 Market Definition
    1.1 Market Segment Overview
    1.2 by Type
    1.3 by End-Use / Application
2 Global Market by Vendors
    2.1 Market Share
    2.2 Vendor Profile
    2.3 Dynamic of Vendors
3 Global Market by Type
    3.1 Market Share
    3.2 Introduction of End-Use by Different Products
4 Global Market by End-Use / Application
    4.1 Market Share
    4.2 Overview of Consumption Characteristics
        4.2.1 Preference Driven
        4.2.2 Substitutability
        4.2.3 Influence by Strategy
        4.2.4 Professional Needs
5 Global Market by Regions
    5.1 Market Share
    5.2 Regional Market Growth
        5.2.1 North America
        5.2.2 Europe
        5.2.3 Asia-Pacific
        5.2.4 South America
        5.2.5 Middle East & Africa
6 North America Market
    6.1 by Type
    6.2 by End-Use / Application
    6.3 by Regions
7 Europe Market
    7.1 by Type
    7.2 by End-Use / Application
    7.3 by Regions
8 Asia-Pacific Market
    8.1 by Type
    8.2 by End-Use / Application
    8.3 by Regions
9 South America Market
    9.1 by Type
    9.2 by End-Use / Application
    9.3 by Regions
10 Middle East & Africa Market
    10.1 by Type
    10.2 by End-Use / Application
    10.3 by Regions
11 Market Forecast
    11.1 Global Market Forecast (2020-2025)
    11.2 Market Forecast by Regions (2020-2025)
    11.3 Market Forecast by Type (2020-2025)
    11.4 Market Forecast by End-Use / Application (2020-2025)
12 Key Manufacturers
    12.MSD  Bristol-Myers Squibb 
        12.1.2 Company Overview
        12.1.2 Product and End-User / Application
        12.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    12.2 GlaxoSmithKline 
    12.3 Menarini 
    12.4 Sanofi 
    12.5 Ziopharm Oncology 
    12.6 Alchemia 
    12.7 Amgen 
    12.8 Apotex 
    12.9 BioMarin Pharmaceutical 
    12.10 CellAct Pharma 
    12.11 Cerulean Pharma 
    12.12 Cipla 
    12.13 Cornerstone Pharmaceuticals 
    12.14 Curis 
    12.15 CytRx 
    12.16 Eli Lilly 
    12.17 Exelixis 
    12.18 Fresenius Kabi 
    12.19 Genentech 
    12.20 Hikma Pharmaceuticals 
    12.21 Hospira 
    12.22 Intas Pharmaceuticals 
    12.23 Karyopharm Therapeutics 
    12.24 Kyowa Hakko Kirin 
    12.25 Ligand Pharmaceuticals
13 Price Overview
    13.1 Price Segment
    13.2 Price Trend
14 Research Conclusion

List of Table


Table Global Drugs for Non-small Cell Lung Cancer Market and Growth by Type
Table Global Drugs for Non-small Cell Lung Cancer Market and Growth by End-Use / Application
Table Global Drugs for Non-small Cell Lung Cancer Revenue (Million USD) by Vendors (2017-2019)
Table Global Drugs for Non-small Cell Lung Cancer Revenue Share by Vendors (2017-2019)
Table Global Drugs for Non-small Cell Lung Cancer Market Volume (Volume) by Vendors (2017-2019)
Table Global Drugs for Non-small Cell Lung Cancer Market Volume Share by Vendors (2017-2019)
Table Headquarter, Factories & Sales Regions Comparison of Vendors
Table Product List of Vendors
Table Global Drugs for Non-small Cell Lung Cancer Market (Million USD) by Type (2017-2019)
Table Global Drugs for Non-small Cell Lung Cancer Market Share by Type (2017-2019)
Table Global Drugs for Non-small Cell Lung Cancer Market Volume (Volume) by Type (2017-2019)
Table Global Drugs for Non-small Cell Lung Cancer Market Volume Share by Type (2017-2019)
Table Global Drugs for Non-small Cell Lung Cancer Market (Million USD) by End-Use / Application (2017-2019)
Table Global Drugs for Non-small Cell Lung Cancer Market Share by End-Use / Application (2017-2019)
Table Global Drugs for Non-small Cell Lung Cancer Market Volume (Volume) by End-Use / Application (2017-2019)
Table Global Drugs for Non-small Cell Lung Cancer Market Volume Share by End-Use / Application (2017-2019)
Table Global Drugs for Non-small Cell Lung Cancer Market (Million USD) by Regions (2017-2019)
Table Global Drugs for Non-small Cell Lung Cancer Market Share by Regions (2017-2019)
Table Global Drugs for Non-small Cell Lung Cancer Market Volume (Volume) by Regions (2017-2019)
Table Global Drugs for Non-small Cell Lung Cancer Market Volume Share by Regions (2017-2019)
Table North America Drugs for Non-small Cell Lung Cancer Market (Million USD) by Type (2017-2019)
Table North America Drugs for Non-small Cell Lung Cancer Market Share by Type (2017-2019)
Table North America Drugs for Non-small Cell Lung Cancer Market (Million USD) by End-Use / Application (2017-2019)
Table North America Drugs for Non-small Cell Lung Cancer Market Share by End-Use / Application (2017-2019)
Table North America Drugs for Non-small Cell Lung Cancer Market (Million USD) by Regions (2017-2019)
Table North America Drugs for Non-small Cell Lung Cancer Market Share by Regions (2017-2019)
Table Europe Drugs for Non-small Cell Lung Cancer Market (Million USD) by Type (2017-2019)
Table Europe Drugs for Non-small Cell Lung Cancer Market Share by Type (2017-2019)
Table Europe Drugs for Non-small Cell Lung Cancer Market (Million USD) by End-Use / Application (2017-2019)
Table Europe Drugs for Non-small Cell Lung Cancer Market Share by End-Use / Application (2017-2019)
Table Europe Drugs for Non-small Cell Lung Cancer Market (Million USD) by Regions (2017-2019)
Table Europe Drugs for Non-small Cell Lung Cancer Market Share by Regions (2017-2019)
Table Asia-Pacific Drugs for Non-small Cell Lung Cancer Market (Million USD) by Type (2017-2019)
Table Asia-Pacific Drugs for Non-small Cell Lung Cancer Market Share by Type (2017-2019)
Table Asia-Pacific Drugs for Non-small Cell Lung Cancer Market (Million USD) by End-Use / Application (2017-2019)
Table Asia-Pacific Drugs for Non-small Cell Lung Cancer Market Share by End-Use / Application (2017-2019)
Table Asia-Pacific Drugs for Non-small Cell Lung Cancer Market (Million USD) by Regions (2017-2019)
Table Asia-Pacific Drugs for Non-small Cell Lung Cancer Market Share by Regions (2017-2019)
Table South America Drugs for Non-small Cell Lung Cancer Market (Million USD) by Type (2017-2019)
Table South America Drugs for Non-small Cell Lung Cancer Market Share by Type (2017-2019)
Table South America Drugs for Non-small Cell Lung Cancer Market (Million USD) by End-Use / Application (2017-2019)
Table South America Drugs for Non-small Cell Lung Cancer Market Share by End-Use / Application (2017-2019)
Table South America Drugs for Non-small Cell Lung Cancer Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Drugs for Non-small Cell Lung Cancer Market Share by Regions (2017-2019)
Table Middle East & Africa Drugs for Non-small Cell Lung Cancer Market (Million USD) by Type (2017-2019)
Table Middle East & Africa Drugs for Non-small Cell Lung Cancer Market Share by Type (2017-2019)
Table Middle East & Africa Drugs for Non-small Cell Lung Cancer Market (Million USD) by End-Use / Application (2017-2019)
Table Middle East & Africa Drugs for Non-small Cell Lung Cancer Market Share by End-Use / Application (2017-2019)
Table Middle East & Africa Drugs for Non-small Cell Lung Cancer Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Drugs for Non-small Cell Lung Cancer Market Share by Regions (2017-2019)
Table Global Drugs for Non-small Cell Lung Cancer Market (Million USD) Forecast by Regions (2020-2025)
Table Global Drugs for Non-small Cell Lung Cancer Market Share Forecast by Regions (2020-2025)
Table Global Drugs for Non-small Cell Lung Cancer Market Volume (Volume) Forecast by Regions (2020-2025)
Table Global Drugs for Non-small Cell Lung Cancer Market Volume Share Forecast by Regions (2020-2025)
Table Global Drugs for Non-small Cell Lung Cancer Market (Million USD) Forecast by Type (2020-2025)
Table Global Drugs for Non-small Cell Lung CancerMarket Share by Forecast Type (2020-2025)
Table Global Drugs for Non-small Cell Lung Cancer Market (Million USD) Forecast by End-Use / Application (2020-2025)
Table Global Drugs for Non-small Cell Lung Cancer Market Share Forecast by End-Use / Application (2020-2025)
Table Sales Revenue, Volume, Price, Cost and Margin of Bristol-Myers Squibb 
Table Sales Revenue, Volume, Price, Cost and Margin of GlaxoSmithKline 
Table Sales Revenue, Volume, Price, Cost and Margin of Menarini 
Table Sales Revenue, Volume, Price, Cost and Margin of Sanofi 
Table Sales Revenue, Volume, Price, Cost and Margin of Ziopharm Oncology 
Table Sales Revenue, Volume, Price, Cost and Margin of Alchemia 
Table Sales Revenue, Volume, Price, Cost and Margin of Amgen 
Table Sales Revenue, Volume, Price, Cost and Margin of Apotex 
Table Sales Revenue, Volume, Price, Cost and Margin of BioMarin Pharmaceutical 
Table Sales Revenue, Volume, Price, Cost and Margin of CellAct Pharma 
Table Sales Revenue, Volume, Price, Cost and Margin of Cerulean Pharma 
Table Sales Revenue, Volume, Price, Cost and Margin of Cipla 
Table Sales Revenue, Volume, Price, Cost and Margin of Cornerstone Pharmaceuticals 
Table Sales Revenue, Volume, Price, Cost and Margin of Curis 
Table Sales Revenue, Volume, Price, Cost and Margin of CytRx 
Table Sales Revenue, Volume, Price, Cost and Margin of Eli Lilly 
Table Sales Revenue, Volume, Price, Cost and Margin of Exelixis 
Table Sales Revenue, Volume, Price, Cost and Margin of Fresenius Kabi 
Table Sales Revenue, Volume, Price, Cost and Margin of Genentech 
Table Sales Revenue, Volume, Price, Cost and Margin of Hikma Pharmaceuticals 
Table Sales Revenue, Volume, Price, Cost and Margin of Hospira 
Table Sales Revenue, Volume, Price, Cost and Margin of Intas Pharmaceuticals 
Table Sales Revenue, Volume, Price, Cost and Margin of Karyopharm Therapeutics 
Table Sales Revenue, Volume, Price, Cost and Margin of Kyowa Hakko Kirin 
Table Sales Revenue, Volume, Price, Cost and Margin of Ligand Pharmaceuticals

List of Figure

Figure Global Drugs for Non-small Cell Lung Cancer Market Size (Million USD) 2017-2025
Figure North America Market Growth 2015-2018
Figure Europe Market Growth 2017-2019
Figure Asia-Pacific Market Growth 2017-2019
Figure South America Market Growth 2017-2019
Figure Middle East & Africa Market Growth 2017-2019
Figure Global Drugs for Non-small Cell Lung Cancer Market (Million USD) and Growth Forecast (2020-2025)
Figure Global Drugs for Non-small Cell Lung Cancer Market Volume (Volume) and Growth Forecast (2020-2025)